- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01329263
Smoking Topography and Harm Exposure in Menthol Cigarettes (MQAT)
December 15, 2014 updated by: Andrew Strasser, University of Pennsylvania
This study will examine how menthol affects smoking when menthol smokers switch to non-menthol cigarettes.
Participants will smoke their preferred brand (control) or Camel Crush cigarettes, which have the ability to be menthol or non-menthol.
Participants given Camel Crush cigarettes will smoke them as menthol, then non-menthol cigarettes for 15 days each.
Participants will provide breath and urine samples, track cigarette usage and complete smoking topography assessments of smoking behavior.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study will examine how menthol affects smoking behaviors and biomarker level when menthol smokers switch to non-menthol cigarettes.
Participants will initially smoke their preferred brand (control) cigarettes, followed by smoking Camel Crush cigarettes, which have the ability to be menthol or non-menthol.
Participants given Camel Crush cigarettes will smoke them as menthol, then non-menthol cigarettes for 15 days each.
Participants will provide breath and urine samples to measure smoke exposures, track cigarette usage to establish changes in daily cigarette consumption and complete smoking topography assessments of smoking behavior, such as puff volume.
Study Type
Interventional
Enrollment (Actual)
87
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Self-report smoking daily cigarettes
- Self-report smoking menthol flavored cigarettes
- Not currently trying to quit or planning to quit in the next 2 months.
- Interested in trying a novel cigarette product and willing to smoke a non-menthol cigarette
- Self-report smoking only filtered commercially made cigarettes
Exclusion Criteria:
- Self-report drinking equal to or greater than a certain number of alcohol-containing drinks per week
- Self report using any nicotine replacement products or nicotine-containing products other than cigarettes
- Self-report substance use disorders in the last 5 years
- Self-report current Axis I psychiatric disorders
- Self-report past history of Axis I psychiatric disorders other than depression
- Self-report myocardial infarction, angina or abnormal rhythms requiring medication
- Self-report use of select medications and illicit drugs within past six months
- Females must not be currently pregnant, planning a pregnancy during the study, or currently breastfeeding/lactating
- Provide a baseline carbon monoxide (CO) reading < 10 ppm at initial session
- Inability to provide informed consent or complete any of the study tasks as determined by the Principal Investigator
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Nonmenthol
Participants switch from menthol to non-menthol cigarettes.
|
Switch from smoking menthol to non-menthol cigarettes.
|
No Intervention: Menthol
Participants smoke own brand of menthol cigarettes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Smoking Topography- Puff Volume
Time Frame: over 35 day study period
|
The total puff volume for a single subject is the sum of puff volumes for a subject's cigarette smoked during the study session.
The mean puff volume for the subjects will be used to examine the effect of cigarette menthol on smoking topography.
The values provided are the average of subjects at study Day 5 (completion of baseline smoking own cigarettes), Day 20 and Day 35.
|
over 35 day study period
|
Smoking Topography- Carbon Monoxide Boost
Time Frame: Measured before and after each cigarette smoked at study sessions
|
Carbon monoxide content in exhaled breath samples is measured before and after each cigarette smoked during study sessions.
CO boost is the amount in parts per million that the subject's CO increases.
|
Measured before and after each cigarette smoked at study sessions
|
Nicotine Levels
Time Frame: 35 days
|
Urine nicotine levels will be measured to examine the effect of cigarette menthol on harm exposure measures.
Participants provided samples on the final day of each period.
NNK and 1-hop were not analyzed, total nicotine metabolites were assayed.
|
35 days
|
Subjective Rating of Cigarettes
Time Frame: Immediately after a cigarette smoked at the study session
|
Subjects completed a visual analog scale rating each cigarette smoked at each session.
Subjects rated characteristics of the cigarette on a scale represented as a continuous horizontal line 10 cm long.
Subjects drew an intersecting line to represent their rating.
The rating reported is for the taste of the cigarette at the end of the period averaged across subjects in the group.
A rating of 0 corresponds to Very Bad and a rating of 100 to Very Good for taste.
There is no better or worse outcome for higher or lower ratings for taste.
|
Immediately after a cigarette smoked at the study session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Andrew A Strasser, Ph.D., University of Pennsylvania
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
September 1, 2011
Study Completion (Actual)
September 1, 2011
Study Registration Dates
First Submitted
April 1, 2011
First Submitted That Met QC Criteria
April 4, 2011
First Posted (Estimate)
April 5, 2011
Study Record Updates
Last Update Posted (Estimate)
January 6, 2015
Last Update Submitted That Met QC Criteria
December 15, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 812369
- R01CA120594 (U.S. NIH Grant/Contract)
- R01CA130961 (U.S. NIH Grant/Contract)
- P30ES013508 (U.S. NIH Grant/Contract)
- P50CA143187 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cigarette Smoking Toxicity
-
Maastricht University Medical CenterCompletedCigarette Smoking | Cigarette Smoking Toxicity | Smoking BehaviorNetherlands
-
University of LouisvilleWithdrawnNicotine | Cigarette Smoking Toxicity | Acute Cardiovascular DiseaseUnited States
-
Duke UniversityGeorgetown University; University of MichiganWithdrawnSmoking | Cigarette Smoking | E-cigarette Use
-
Assistance Publique - Hôpitaux de ParisUnknownSmoking Cessation | Smoking, Cigarette | Electronic CigaretteFrance
-
Yale UniversityNational Cancer Institute (NCI)RecruitingSmoking Cessation | Cigarette Smoking | E-Cigarette UseUnited States
-
Medical University of South CarolinaAmerican Cancer Society, Inc.RecruitingSmoking Cessation | Electronic Cigarette Use | Cigarette SmokingUnited States
-
University of St AndrewsNational Health Service, United KingdomUnknownSmoking | Cigarette Smoking | Smoking, Tobacco
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI); New York University; Stanford UniversityRecruitingSmoking | Smoking, Tobacco | Smoking, CigaretteUnited States
-
BIDI VaporCompletedCigarette Smoking | E-cigarette UsePoland
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
Clinical Trials on Menthol to non-menthol
-
University of MinnesotaCompleted
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); University of MinnesotaRecruitingSmoking Prevention and ControlUnited States
-
Altria Client Services LLCCelerionRecruiting
-
Ohio State University Comprehensive Cancer CenterNational Institute on Drug Abuse (NIDA); Brown University; National Institutes... and other collaboratorsCompletedSmoking (Tobacco) AddictionUnited States
-
University of MinnesotaNational Institute on Drug Abuse (NIDA)CompletedTobacco Use DisorderUnited States
-
Yale UniversityRecruiting
-
University of Sao PauloUniversidade Estadual de LondrinaCompleted
-
Hospital de MataróCompleted
-
Philip Morris Products S.A.Completed
-
University of Sao PauloUniversidade Estadual de LondrinaUnknownThirst | Perioperative NursingBrazil